Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Mar;306(2):169-72.
doi: 10.1007/BF00498987.

The effect of naloxone on cerebellar cGMP content. A possible GABA-antagonistic action?

The effect of naloxone on cerebellar cGMP content. A possible GABA-antagonistic action?

S W Gumulka et al. Naunyn Schmiedebergs Arch Pharmacol. 1979 Mar.

Abstract

Naloxone in high doses (60--240 mg/kg i.p.) produced a dose-dependent increase in cerebellar cGMP content of mice. The rise in cGMP content reached its maximum within 5 min and was of short duration. Short-lasting episodes of clonic seizures were noted after 240 mg/kg naloxone. Low doses of naloxone (5--10 mg/kg) had no effect on cerebellar cGMP content, but markedly potentiated the increase in cGMP induced by isoniazid. On the other hand, naloxone (5 mg/kg) partially antagonized the fall in cGMP elicited by diazepam, but had only a slight effect on the action of pentobarbital (30 mg/kg i.p.). These results support the assumption proposed by other authors that naloxone exerts GABA antagonistic effects aside from the potent opiate receptor antagonistic activity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Adv Biochem Psychopharmacol. 1975;(14):113-30 - PubMed
    1. Psychopharmacology (Berl). 1976 Nov 24;50(3):241-4 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1974;284(1):55-61 - PubMed
    1. Life Sci. 1975 Jul 15;17(2):167-85 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1976;292(3):259-65 - PubMed